{"id":"W2526225966","doi":"10.1182/blood.v126.23.505.505","title":"Pembrolizumab in Combination with Lenalidomide and Low-Dose Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM): Keynote-023","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Tolerability; Pembrolizumab; Dexamethasone; Internal medicine; Multiple myeloma; Oncology; Clinical endpoint; Phases of clinical research; Neutropenia; Gastroenterology; Surgery; Adverse effect; Clinical trial; Toxicity; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003655882,0.0002185814,0.0003889418,0.0002403197,0.00006541288,0.00003124113,0.00007778368,0.0001248212,0.00001114921],"category_scores_gemma":[0.0009263147,0.0001702713,0.00005266821,0.0002100962,0.0001030744,0.0001756444,0.00004569861,0.0002134165,0.00002111206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001275796,"about_ca_system_score_gemma":0.0002810167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000281322,"about_ca_topic_score_gemma":0.0003432408,"domain_scores_codex":[0.9983939,0.00008884639,0.000261007,0.0003939491,0.000419368,0.0004429643],"domain_scores_gemma":[0.9985924,0.0003741684,0.00008813123,0.0003098543,0.0002172875,0.0004181525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03805346,0.01092607,0.8862179,0.0006632591,0.0007388525,0.001262637,0.001679368,0.0000226418,0.01386897,0.0002287399,0.0006251428,0.04571298],"study_design_scores_gemma":[0.344283,0.007463283,0.6184185,0.000465516,0.0003114569,0.0003193113,0.0004592153,0.003303854,0.02283724,0.0004494585,0.001260013,0.0004292398],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966264,0.0007319064,0.0002148201,0.0003312071,0.0000438576,0.001503991,0.00002852475,0.00006029381,0.0004589781],"genre_scores_gemma":[0.9939395,0.00006265769,0.004868637,0.00007355405,0.00007044859,0.0002597388,0.0001353705,0.00004805637,0.000542004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3062295,"threshold_uncertainty_score":0.6943464,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03552536455554776,"score_gpt":0.2941909044543848,"score_spread":0.2586655398988371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}